Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $0.19 in the prior trading day, Klotho Neurosciences Inc (NASDAQ: KLTO) closed at $0.21, up 7.12%. In other words, the price has increased by $7.12 from its previous closing price. On the day, 4.54 million shares were traded.
Ratios:
Our goal is to gain a better understanding of KLTO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29. In the meantime, Its Debt-to-Equity ratio is 2.77 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 02 ’24 when CHARDAN CAPITAL MARKETS LLC sold 180,000 shares for $2.05 per share. The transaction valued at 368,442 led to the insider holds 1,284,364 shares of the business.
CHARDAN CAPITAL MARKETS LLC sold 115,136 shares of KLTO for $237,618 on Jul 01 ’24. The 10% Owner now owns 1,464,364 shares after completing the transaction at $2.06 per share. On Jun 28 ’24, another insider, CHARDAN CAPITAL MARKETS LLC, who serves as the 10% Owner of the company, sold 47,000 shares for $2.53 each. As a result, the insider received 119,103 and left with 1,579,500 shares of the company.
Stock Price History:
Over the past 52 weeks, KLTO has reached a high of $8.11, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is 3.43%, while the 200-Day Moving Average is calculated to be -55.81%.
Shares Statistics:
A total of 28.51M shares are outstanding, with a floating share count of 26.77M. Insiders hold about 17.63% of the company’s shares, while institutions hold 2.60% stake in the company.
